My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 576

    1.

    Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.

    Kriechbaum K, Michels S, Prager F, Georgopoulos M, Funk M, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Apr;92(4):518-22. Epub 2008 Jan 22.PMID: 18211942 [PubMed - indexed for MEDLINE]Related articles

    2.

    Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.

    Prager F, Michels S, Kriechbaum K, Georgopoulos M, Funk M, Geitzenauer W, Polak K, Schmidt-Erfurth U.

    Br J Ophthalmol. 2009 Apr;93(4):452-6. Epub 2008 Dec 15.PMID: 19074916 [PubMed - indexed for MEDLINE]Related articles

    3.

    Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up.

    Wu L, Arevalo JF, Roca JA, Maia M, Berrocal MH, Rodriguez FJ, Evans T, Costa RA, Cardillo J; Pan-American Collaborative Retina Study Group (PACORES).

    Retina. 2008 Feb;28(2):212-9.PMID: 18301025 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.

    Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK, Babu RB, Narayana KM.

    Am J Ophthalmol. 2007 Apr;143(4):601-6. Epub 2007 Feb 15.PMID: 17306753 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion.

    Ahmadi AA, Chuo JY, Banashkevich A, Ma PE, Maberley DA.

    Can J Ophthalmol. 2009 Apr;44(2):154-9.PMID: 19491948 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Retina. 2007 Feb;27(2):141-9.PMID: 17290194 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.

    Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, Alge CS, Kunze C, Haritoglou C, Kampik A.

    Retina. 2007 Oct;27(8):1004-12.PMID: 18040236 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion.

    Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R, Kunze C, Haritoglou C, Kampik A, Priglinger S.

    Br J Ophthalmol. 2008 Mar;92(3):351-5. Epub 2008 Jan 22.PMID: 18211925 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.

    Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL.

    Retina. 2007 Apr-May;27(4):419-25.PMID: 17420692 [PubMed - indexed for MEDLINE]Related articles

    10.

    Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.

    Rensch F, Jonas JB, Spandau UH.

    Acta Ophthalmol. 2009 Feb;87(1):77-81. Epub 2008 Oct 17.PMID: 18937800 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.

    Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL, Sorenson J, Slakter JS, Freund KB, Cooney M, Fine HF.

    Retina. 2006 Mar;26(3):279-84.PMID: 16508427 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema.

    Fang X, Sakaguchi H, Gomi F, Oshima Y, Sawa M, Tsujikawa M, Ikuno Y, Kamei M, Kusaka S, Tano Y.

    Acta Ophthalmol. 2008 Nov;86(7):800-5. Epub 2008 Jun 11.PMID: 18547274 [PubMed - indexed for MEDLINE]Related articles

    13.

    Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.

    Retina. 2008 Oct;28(8):1053-60.PMID: 18779710 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion.

    Gregori NZ, Gaitan J, Rosenfeld PJ, Puliafito CA, Feuer W, Flynn HW Jr, Berrocal AM, Al-Attar L, Dubovy S, Smiddy WE, Schwartz SG, Lee WH, Murray TG.

    Retina. 2008 Oct;28(9):1325-37.PMID: 19430392 [PubMed - indexed for MEDLINE]Related articles

    15.

    Treatment of central retinal vein occlusion-related macular edema with intravitreal bevacizumab (Avastin): preliminary results.

    Pournaras JA, Nguyen C, Vaudaux JD, Konstantinidis L, Ambresin A, Wolfensberger T.

    Klin Monbl Augenheilkd. 2008 May;225(5):397-400.PMID: 18454380 [PubMed - indexed for MEDLINE]Related articles

    16.

    Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion.

    Gregori NZ, Rattan GH, Rosenfeld PJ, Puliafito CA, Feuer W, Flynn HW Jr, Berrocal AM, Al-Attar L, Dubovy S, Smiddy WE, Schwartz SG, Lee WH, Murray TG.

    Retina. 2009 Jul-Aug;29(7):913-25.PMID: 19584649 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.

    Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, Klein R.

    Am J Ophthalmol. 2009 Feb;147(2):298-306. Epub 2008 Oct 17.PMID: 18929354 [PubMed - indexed for MEDLINE]Related articles

    18.

    Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study.

    Moschos MM, Moschos M.

    Doc Ophthalmol. 2008 Mar;116(2):147-52. Epub 2008 Jan 10.PMID: 18189152 [PubMed - indexed for MEDLINE]Related articles

    19.

    Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular edema.

    Shetty R, Pai SA, Vincent A, Shetty N, Narayana KM, Sinha B, Shetty BK.

    Doc Ophthalmol. 2008 Mar;116(2):129-35. Epub 2007 Oct 25.PMID: 17960440 [PubMed - indexed for MEDLINE]Related articles

    20.

    Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.

    Russo V, Barone A, Conte E, Prascina F, Stella A, Noci ND.

    Retina. 2009 Apr;29(4):511-5.PMID: 19174717 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity